• Results
  • Access strategies: Results Part IV: What does access look like for self-administe...
Access strategies: Results Part IV

What does access look like for self-administered products?

This part four of a four part series, looks at whether companies tailor their access strategies for self-administered products, which are particularly useful in low- and middle-income countries and resource-limited health systems, to reach a larger proportion of patients in these countries.

Explore further

How we measure

How we measure

The Index evaluates pharmaceutical companies in areas where they have the biggest potential and responsibility to make change, such as R&D and pricing. Find out more about the analytical framework and areas of evaluation.

Get in touch

Back to top |